Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Immucell (ICCC) Leases (2020 - 2025)

Historic Leases for Immucell (ICCC) over the last 6 years, with Q3 2025 value amounting to $4.4 million.

  • Immucell's Leases fell 377.1% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 377.1%. This contributed to the annual value of $4.6 million for FY2024, which is 22.9% down from last year.
  • As of Q3 2025, Immucell's Leases stood at $4.4 million, which was down 377.1% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Leases ranged from a high of $4.6 million in Q3 2024 and a low of $1.1 million during Q2 2022
  • Over the past 5 years, Immucell's median Leases value was $4.2 million (recorded in 2023), while the average stood at $3.1 million.
  • In the last 5 years, Immucell's Leases tumbled by 975.49% in 2022 and then skyrocketed by 30765.46% in 2023.
  • Quarter analysis of 5 years shows Immucell's Leases stood at $1.1 million in 2021, then soared by 97.87% to $2.2 million in 2022, then skyrocketed by 108.28% to $4.6 million in 2023, then decreased by 0.23% to $4.6 million in 2024, then decreased by 3.09% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $4.5 million for Q2 2025, and $4.5 million during Q1 2025.